Table 1—

Patients with a follow-up CAG: baseline characteristics with regard to pancreas loss

Pancreas loss before follow-up CAG
P*
No (n = 26)Yes (n = 6)
Men20 (77%)5 (83%)0.73
Age (years)37.5 (7.1)35.0 (4.3)0.42
Weight (kg)68.7 (8.9)71.0 (6.1)0.55
Length (m)1.75 (0.08)1.77 (0.08)0.69
BMI (kg/m2)22.5 (3.0)22.8 (1.3)0.80
Duration of diabetes (years)24.3 (6.2)21.3 (5.2)0.29
Months on dialysis: median (IQR)12 (14)11 (12.)0.71
Statin medication1 (4%)0 (0%)0.65
ACE-inhibiting medication13 (52%)4 (80%)0.25
β-blocking medication4 (16%)1 (20%)0.83
Diuretic medication10 (40%)3 (60%)0.41
HbA1c (mmol/l)8.58 (1.52)9.62 (2.83)0.21
Albumin (g/l)42.0 (4.0)42.2 (5.0)0.93
Systolic blood pressure (mmHg)160 (24)154 (15)0.62
Diastolic blood pressure (mmHg)87 (9)90 (8)0.56
Total cholesterol (mmol/l)6.28 (1.25)7.10 (0.90)0.21
Triglycerides (mmol/l)2.28 (0.95)3.08 (1.47)0.13
Smoking: never/ever/current (n)9/11/43/1/10.21
Rejection episodes3 (0–4)2 (0–2)0.64
Baseline MSD (mm)3.05 (0.41)3.21 (0.41)0.43
Baseline MOD (mm)2.26 (0.60)2.09 (0.82)0.61
  • *

    * Data are n (%), means (SD), and median (range) unless otherwise indicated. P value of Student’s t test, Mann-Whitney U-test, or χ2 test, where appropriate. IQR, interquartile range.